Fox Chase Cancer Center Researcher Sanjeevani Arora Recognized by JAMA Network Open as a Distinguished Reviewer

Sanjeevani Arora, PhD,
Sanjeevani Arora, PhD, Assistant Professor in the Cancer Prevention and Control Research Program and a member of the Cancer Epigenetics Institute at Fox Chase Cancer Center.

PHILADELPHIA (July 15, 2025) — Sanjeevani Arora, PhD, Assistant Professor in the Cancer Prevention and Control Research Program and a member of the Cancer Epigenetics Institute at Fox Chase Cancer Center, was recently recognized by the Journal of the American Medical Association (JAMA) Network Open for significant contributions in her role as a reviewer.


“Being named a Distinguished Reviewer by JAMA Network Open is truly an honor. Peer review is a cornerstone of the scientific process, and I view it as both a responsibility and a privilege to contribute to that process,” said Arora.


According to JAMA, a Distinguished Reviewer consistently provides high-quality peer reviews ranked very good or excellent by the journal’s editorial team. These rankings not only allow editors to make timely decisions regarding journal publications but also contribute substantially to the overall quality and impact of the journal.


In a formal letter to Arora, Eli N. Perencevich, MD, MS, Editor in Chief of JAMA Network Open, noted her professionalism, attention to detail, and commitment to turnaround time as key factors that have resulted in her recognition as a Distinguished Reviewer.


“We want to formally thank you for the key role you have played in the success of the journal’s peer review process, which has allowed JAMA Network Open to remain one of the top open-access general medical journals in the world,” Perencevich wrote.


“This recognition affirms the value of thoughtful, rigorous critique in advancing medical science, and I am proud to represent Fox Chase Cancer Center in upholding these standards,” said Arora. “It’s especially meaningful to be part of a journal that continues to shape high-impact, accessible research in medicine.”
JAMA Network Open, which was established in 2018, is an international, peer reviewed, open-access medical journal that includes the latest research on wide-ranging topics such as clinical care, health policy, global health, and innovation in healthcare. 


The mission of JAMA Network Open is to improve healthcare and health equity worldwide by providing access to high quality and innovative medical research and commentary by some of the world’s top medical professionals. The journal was created by and for a broad range of clinicians, researchers, policy makers, and public health and healthcare leaders.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427